This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02549/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02549/identifier/pubchem-compound/
n9http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB02549/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n4http://linked.opendata.cz/resource/drugbank/drug/DB02549/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n8http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02549
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n6:DB02549 n9:DB02549
dcterms:title
3'-O-Acetylthymidine-5'-Diphosphate
adms:identifier
n4:DB02549 n11:46506629 n12:ATY n13:46936421
n7:IUPAC-Name
n8:271B41A8-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B41AE-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B41AD-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B41AA-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B41AB-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B41AC-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B41A6-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B41A4-363D-11E5-9242-09173F13E4C5 n8:271B41A7-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B41A5-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B41B4-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B41B5-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B41AF-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B41B0-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B41B2-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B41B1-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B41B3-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B41BA-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B41BC-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B41BD-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B41B9-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B41B8-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B41BB-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B41A9-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B41B6-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B41B7-363D-11E5-9242-09173F13E4C5